60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Short Interest Update

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totaling 511 shares, a decrease of 35.6% from the December 15th total of 793 shares. Based on an average daily trading volume, of 5,628 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 5,628 shares, the days-to-cover ratio is presently 0.1 days.

60 Degrees Pharmaceuticals Stock Up 8.7%

60 Degrees Pharmaceuticals stock traded up $0.00 during mid-day trading on Friday, reaching $0.06. 4,970 shares of the stock traded hands, compared to its average volume of 2,081. The business’s 50-day moving average is $0.05 and its 200-day moving average is $0.06. 60 Degrees Pharmaceuticals has a 12-month low of $0.02 and a 12-month high of $0.16.

About 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.